Additional findings_Adult

Gene: CDKN2A

Green List (high evidence)

CDKN2A (cyclin dependent kinase inhibitor 2A, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000147889
EnsemblGeneIds (GRCh37): ENSG00000147889
OMIM: 600160, ClinGen, DECIPHER
CDKN2A is in 16 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

MODERATE actionability by ClinGen.

Refer to cancer genetics services, surveillance for melanoma and pancreatic cancer available.
Sources: Expert list
Created: 22 Apr 2025, 6:33 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
{Melanoma-pancreatic cancer syndrome} MIM#606719

History Filter Activity

22 Apr 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: cdkn2a has been classified as Green List (High Evidence).

22 Apr 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: cdkn2a has been classified as Green List (High Evidence).

22 Apr 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: CDKN2A was added gene: CDKN2A was added to Additional findings_Adult. Sources: Expert list Mode of inheritance for gene: CDKN2A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: CDKN2A were set to {Melanoma-pancreatic cancer syndrome} MIM#606719 Review for gene: CDKN2A was set to GREEN